← FDA Drug Approvals (Drugs@FDA)
LAZANDA
NDA · New Drug Application · Sponsor: BTCP PHARMA · Approved 2011-06-30
Drug application
- FDA Application #
NDA022569
- Application type
- New Drug Application
- Brand name
- LAZANDA
- Generic name
- Fentanyl Citrate
- Active ingredients
- FENTANYL CITRATE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Discontinued
- Sponsor
- BTCP PHARMA
- First approval
- 2011-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown